| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 81 | 2023 | 421 | 13.750 |
Why?
|
| Retinal Neovascularization | 33 | 2023 | 244 | 8.500 |
Why?
|
| Retinal Vessels | 36 | 2021 | 772 | 4.650 |
Why?
|
| Choroidal Neovascularization | 9 | 2022 | 343 | 3.650 |
Why?
|
| Retina | 34 | 2022 | 2616 | 3.240 |
Why?
|
| Insulin-Like Growth Factor I | 35 | 2021 | 2015 | 2.960 |
Why?
|
| Fatty Acids, Omega-3 | 16 | 2022 | 1344 | 2.910 |
Why?
|
| Neovascularization, Pathologic | 23 | 2021 | 2635 | 2.680 |
Why?
|
| Infant, Premature | 35 | 2023 | 2044 | 2.390 |
Why?
|
| Vascular Endothelial Growth Factor A | 49 | 2022 | 3508 | 2.200 |
Why?
|
| Macular Degeneration | 11 | 2022 | 980 | 2.130 |
Why?
|
| Angiogenesis Inhibitors | 14 | 2022 | 2038 | 1.740 |
Why?
|
| Oxygen | 28 | 2022 | 4189 | 1.740 |
Why?
|
| Neovascularization, Physiologic | 11 | 2020 | 1351 | 1.710 |
Why?
|
| Retinal Diseases | 10 | 2018 | 683 | 1.440 |
Why?
|
| Photoreceptor Cells | 3 | 2021 | 244 | 1.400 |
Why?
|
| Infant, Newborn | 89 | 2023 | 25625 | 1.320 |
Why?
|
| Adiponectin | 5 | 2022 | 1100 | 1.300 |
Why?
|
| Retinal Neurons | 5 | 2018 | 66 | 1.280 |
Why?
|
| Fibroblast Growth Factors | 3 | 2020 | 879 | 1.260 |
Why?
|
| Endothelial Growth Factors | 15 | 2003 | 694 | 1.260 |
Why?
|
| Diabetic Retinopathy | 7 | 2020 | 1210 | 1.220 |
Why?
|
| Disease Models, Animal | 39 | 2022 | 18029 | 1.210 |
Why?
|
| Choroid | 3 | 2020 | 322 | 1.180 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2018 | 204 | 1.150 |
Why?
|
| Erythropoietin | 9 | 2018 | 726 | 1.150 |
Why?
|
| Lymphokines | 14 | 2003 | 949 | 1.050 |
Why?
|
| Vascular Endothelial Growth Factors | 17 | 2016 | 772 | 0.980 |
Why?
|
| Microvessels | 3 | 2020 | 544 | 0.960 |
Why?
|
| Biological Assay | 2 | 2020 | 652 | 0.950 |
Why?
|
| Gestational Age | 34 | 2023 | 3493 | 0.940 |
Why?
|
| Ophthalmology | 5 | 2017 | 508 | 0.940 |
Why?
|
| Receptors, LDL | 4 | 2017 | 475 | 0.940 |
Why?
|
| Hyperglycemia | 3 | 2023 | 1373 | 0.940 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2016 | 390 | 0.900 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2015 | 175 | 0.900 |
Why?
|
| Mice | 76 | 2023 | 81183 | 0.890 |
Why?
|
| Docosahexaenoic Acids | 7 | 2023 | 875 | 0.860 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2020 | 1222 | 0.850 |
Why?
|
| Animals | 101 | 2023 | 168757 | 0.850 |
Why?
|
| Birth Weight | 14 | 2021 | 2069 | 0.790 |
Why?
|
| Mice, Inbred C57BL | 41 | 2022 | 21827 | 0.790 |
Why?
|
| Propranolol | 2 | 2012 | 502 | 0.750 |
Why?
|
| Fatty Acids | 6 | 2023 | 1809 | 0.730 |
Why?
|
| Laser Coagulation | 4 | 2018 | 326 | 0.690 |
Why?
|
| Arachidonic Acid | 6 | 2023 | 434 | 0.690 |
Why?
|
| Fluorescein Angiography | 6 | 2019 | 940 | 0.680 |
Why?
|
| Weight Gain | 10 | 2017 | 2292 | 0.650 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 8 | 2021 | 424 | 0.600 |
Why?
|
| Sirtuin 1 | 3 | 2014 | 246 | 0.600 |
Why?
|
| Endothelium, Vascular | 13 | 2020 | 4456 | 0.580 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2012 | 1240 | 0.570 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2012 | 4751 | 0.560 |
Why?
|
| Capillary Permeability | 2 | 2020 | 798 | 0.560 |
Why?
|
| Fenofibrate | 1 | 2016 | 88 | 0.550 |
Why?
|
| Premature Birth | 4 | 2022 | 1721 | 0.550 |
Why?
|
| Neonatal Screening | 8 | 2023 | 591 | 0.540 |
Why?
|
| Fatty Acids, Unsaturated | 5 | 2022 | 546 | 0.520 |
Why?
|
| Endothelial Cells | 15 | 2022 | 3479 | 0.520 |
Why?
|
| Infant, Low Birth Weight | 6 | 2019 | 850 | 0.510 |
Why?
|
| Acetates | 1 | 2016 | 311 | 0.510 |
Why?
|
| Signal Transduction | 13 | 2020 | 23403 | 0.500 |
Why?
|
| Animals, Newborn | 11 | 2016 | 2726 | 0.500 |
Why?
|
| Frizzled Receptors | 2 | 2012 | 91 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 575 | 0.490 |
Why?
|
| RNA, Messenger | 20 | 2014 | 13033 | 0.480 |
Why?
|
| Ischemia | 7 | 2016 | 1907 | 0.480 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 419 | 0.480 |
Why?
|
| Fetal Development | 2 | 2016 | 767 | 0.460 |
Why?
|
| Optic Nerve Diseases | 1 | 2017 | 327 | 0.450 |
Why?
|
| Neuroglia | 2 | 2016 | 927 | 0.450 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 2009 | 216 | 0.450 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 257 | 0.430 |
Why?
|
| Vitreous Body | 4 | 2020 | 389 | 0.420 |
Why?
|
| Optic Disk Drusen | 1 | 2012 | 35 | 0.410 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2012 | 114 | 0.410 |
Why?
|
| Lipid Metabolism | 4 | 2017 | 1889 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2003 | 552 | 0.400 |
Why?
|
| Mice, Knockout | 14 | 2021 | 14557 | 0.400 |
Why?
|
| Goals | 1 | 2017 | 706 | 0.400 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1116 | 0.400 |
Why?
|
| Receptors, Growth Factor | 4 | 2002 | 334 | 0.400 |
Why?
|
| Stilbenes | 2 | 2014 | 156 | 0.390 |
Why?
|
| Humans | 138 | 2023 | 744343 | 0.390 |
Why?
|
| Quinolines | 1 | 2016 | 732 | 0.390 |
Why?
|
| Retinal Telangiectasis | 1 | 2011 | 24 | 0.390 |
Why?
|
| Visual Acuity | 3 | 2019 | 2530 | 0.390 |
Why?
|
| Sphingolipids | 2 | 2022 | 159 | 0.380 |
Why?
|
| Interleukin-18 | 1 | 2012 | 249 | 0.380 |
Why?
|
| Research | 1 | 2019 | 1999 | 0.370 |
Why?
|
| PPAR gamma | 2 | 2011 | 493 | 0.370 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2011 | 144 | 0.370 |
Why?
|
| Blindness | 4 | 2020 | 617 | 0.350 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 9438 | 0.350 |
Why?
|
| Retinitis Pigmentosa | 2 | 2021 | 386 | 0.350 |
Why?
|
| Complement System Proteins | 1 | 2013 | 795 | 0.350 |
Why?
|
| Milk, Human | 3 | 2019 | 490 | 0.350 |
Why?
|
| Regeneration | 3 | 2013 | 1485 | 0.340 |
Why?
|
| Eye | 3 | 2016 | 729 | 0.340 |
Why?
|
| DNA Primers | 5 | 2008 | 2892 | 0.340 |
Why?
|
| Melanoma, Experimental | 1 | 2012 | 561 | 0.330 |
Why?
|
| Cell Proliferation | 8 | 2017 | 10481 | 0.330 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 822 | 0.330 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2012 | 1660 | 0.310 |
Why?
|
| Infant | 26 | 2023 | 35136 | 0.310 |
Why?
|
| Dietary Fats | 4 | 2021 | 2017 | 0.310 |
Why?
|
| Blotting, Western | 8 | 2017 | 5179 | 0.310 |
Why?
|
| Monocytes | 2 | 2014 | 2596 | 0.300 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2018 | 227 | 0.290 |
Why?
|
| Eye Proteins | 5 | 2016 | 646 | 0.280 |
Why?
|
| Fat Emulsions, Intravenous | 3 | 2018 | 321 | 0.270 |
Why?
|
| Carrier Proteins | 4 | 2021 | 5021 | 0.270 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 12072 | 0.270 |
Why?
|
| PPAR alpha | 2 | 2017 | 197 | 0.270 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 3505 | 0.270 |
Why?
|
| Angiopoietin-1 | 3 | 2012 | 114 | 0.260 |
Why?
|
| Eye Diseases | 2 | 2010 | 669 | 0.260 |
Why?
|
| Retinal Ganglion Cells | 5 | 2013 | 770 | 0.260 |
Why?
|
| Hyperoxia | 5 | 2016 | 262 | 0.260 |
Why?
|
| Infant, Premature, Diseases | 2 | 2022 | 706 | 0.260 |
Why?
|
| Neurons | 6 | 2017 | 9338 | 0.250 |
Why?
|
| Adiposity | 1 | 2015 | 1807 | 0.250 |
Why?
|
| Fundus Oculi | 5 | 2019 | 473 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4462 | 0.250 |
Why?
|
| Energy Metabolism | 1 | 2016 | 2899 | 0.250 |
Why?
|
| Recombinant Proteins | 6 | 2021 | 6622 | 0.250 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 846 | 0.250 |
Why?
|
| Retinal Degeneration | 3 | 2021 | 415 | 0.250 |
Why?
|
| Bronchopulmonary Dysplasia | 5 | 2018 | 306 | 0.240 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 669 | 0.240 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2019 | 428 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3336 | 0.220 |
Why?
|
| Nerve Growth Factors | 4 | 2016 | 574 | 0.220 |
Why?
|
| Severity of Illness Index | 8 | 2020 | 15540 | 0.220 |
Why?
|
| Cells, Cultured | 11 | 2020 | 19229 | 0.220 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2004 | 177 | 0.220 |
Why?
|
| Antioxidants | 1 | 2011 | 1663 | 0.220 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7913 | 0.220 |
Why?
|
| Flunarizine | 1 | 2022 | 7 | 0.220 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2023 | 1164 | 0.220 |
Why?
|
| Macrophages | 3 | 2014 | 5655 | 0.220 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2022 | 31 | 0.220 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2022 | 39 | 0.220 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 9734 | 0.220 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2015 | 546 | 0.220 |
Why?
|
| Male | 62 | 2023 | 350118 | 0.220 |
Why?
|
| Sphingosine | 2 | 2023 | 307 | 0.210 |
Why?
|
| Sweden | 7 | 2021 | 1345 | 0.210 |
Why?
|
| Female | 68 | 2023 | 380194 | 0.210 |
Why?
|
| Angiopoietin-2 | 3 | 2012 | 173 | 0.210 |
Why?
|
| Lysophospholipids | 2 | 2023 | 331 | 0.210 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 229 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4042 | 0.200 |
Why?
|
| Risk Factors | 24 | 2023 | 72290 | 0.200 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2020 | 406 | 0.200 |
Why?
|
| Gene Dosage | 2 | 2005 | 1252 | 0.200 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2016 | 367 | 0.200 |
Why?
|
| Peptide Nucleic Acids | 1 | 2021 | 25 | 0.200 |
Why?
|
| Vision, Ocular | 1 | 2004 | 464 | 0.190 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2001 | 76 | 0.190 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 5 | 2012 | 664 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 873 | 0.190 |
Why?
|
| Parenteral Nutrition | 3 | 2023 | 650 | 0.180 |
Why?
|
| Receptor, TIE-2 | 4 | 2014 | 178 | 0.180 |
Why?
|
| Stem Cell Transplantation | 2 | 2010 | 1620 | 0.180 |
Why?
|
| Transcription Factors | 5 | 2020 | 12208 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2017 | 4420 | 0.180 |
Why?
|
| Blood-Retinal Barrier | 1 | 2020 | 62 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 2 | 2020 | 317 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2018 | 10943 | 0.170 |
Why?
|
| Microglia | 1 | 2007 | 1266 | 0.170 |
Why?
|
| Intravitreal Injections | 5 | 2022 | 344 | 0.170 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2001 | 434 | 0.160 |
Why?
|
| Models, Biological | 2 | 2013 | 9583 | 0.160 |
Why?
|
| Interleukin-6 | 3 | 2017 | 3200 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2019 | 140 | 0.160 |
Why?
|
| Receptors, Erythropoietin | 2 | 2008 | 147 | 0.160 |
Why?
|
| Inflammation | 2 | 2017 | 10638 | 0.160 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 7722 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 4 | 2019 | 6171 | 0.160 |
Why?
|
| Enteral Nutrition | 2 | 2021 | 763 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1999 | 433 | 0.150 |
Why?
|
| Leukocytosis | 1 | 2019 | 247 | 0.150 |
Why?
|
| National Eye Institute (U.S.) | 1 | 2017 | 4 | 0.150 |
Why?
|
| Choroid Neoplasms | 1 | 2019 | 175 | 0.150 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2019 | 91 | 0.150 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2017 | 67 | 0.150 |
Why?
|
| Receptors, Adiponectin | 1 | 2017 | 81 | 0.150 |
Why?
|
| Infant Mortality | 1 | 2022 | 754 | 0.150 |
Why?
|
| Cell Hypoxia | 3 | 2014 | 675 | 0.150 |
Why?
|
| Pregnancy | 11 | 2022 | 29144 | 0.140 |
Why?
|
| Retinoids | 1 | 2017 | 101 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 2 | 2004 | 2007 | 0.140 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 2513 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2020 | 2499 | 0.140 |
Why?
|
| Electroretinography | 1 | 2018 | 509 | 0.140 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 198 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2013 | 4217 | 0.140 |
Why?
|
| Conjunctivitis, Viral | 1 | 1995 | 6 | 0.140 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 78 | 0.130 |
Why?
|
| Volatilization | 1 | 2015 | 82 | 0.130 |
Why?
|
| Sulfides | 1 | 2016 | 165 | 0.130 |
Why?
|
| Conjunctivitis, Bacterial | 1 | 1995 | 24 | 0.130 |
Why?
|
| Bruch Membrane | 1 | 2015 | 64 | 0.130 |
Why?
|
| Capillaries | 1 | 2019 | 773 | 0.130 |
Why?
|
| Dietary Supplements | 2 | 2021 | 3297 | 0.130 |
Why?
|
| Lasers | 2 | 2017 | 952 | 0.130 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 290 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 377 | 0.130 |
Why?
|
| Cyclopropanes | 1 | 2016 | 416 | 0.130 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 391 | 0.130 |
Why?
|
| Diet | 4 | 2018 | 7939 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 4554 | 0.120 |
Why?
|
| Growth Hormone | 1 | 1997 | 705 | 0.120 |
Why?
|
| Pyrroles | 1 | 2001 | 1146 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2018 | 972 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2012 | 3920 | 0.120 |
Why?
|
| Lipoxygenase | 1 | 2014 | 74 | 0.120 |
Why?
|
| Biotransformation | 1 | 2014 | 168 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 2187 | 0.120 |
Why?
|
| Administration, Oral | 2 | 2012 | 3913 | 0.120 |
Why?
|
| Angiostatic Proteins | 1 | 2013 | 2 | 0.120 |
Why?
|
| Cattle | 5 | 2003 | 3922 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 3 | 2018 | 2647 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 473 | 0.110 |
Why?
|
| Hemangioma | 1 | 2019 | 738 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2011 | 528 | 0.110 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2013 | 13 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2004 | 3386 | 0.110 |
Why?
|
| Fish Oils | 1 | 2017 | 470 | 0.110 |
Why?
|
| Light | 2 | 1994 | 1374 | 0.110 |
Why?
|
| Plasma | 1 | 2017 | 575 | 0.110 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2013 | 302 | 0.110 |
Why?
|
| Laser Therapy | 3 | 2015 | 1072 | 0.110 |
Why?
|
| Indoles | 2 | 2001 | 1839 | 0.110 |
Why?
|
| Integrases | 2 | 2014 | 533 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2019 | 454 | 0.110 |
Why?
|
| Epoxide Hydrolases | 1 | 2014 | 122 | 0.110 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 104 | 0.110 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2014 | 329 | 0.110 |
Why?
|
| Membrane Proteins | 3 | 2017 | 7880 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2015 | 317 | 0.110 |
Why?
|
| Aorta | 3 | 2016 | 2061 | 0.110 |
Why?
|
| Platelet Count | 3 | 2021 | 781 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2018 | 1534 | 0.110 |
Why?
|
| Wet Macular Degeneration | 1 | 2014 | 145 | 0.110 |
Why?
|
| Retrospective Studies | 16 | 2023 | 77449 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 351 | 0.100 |
Why?
|
| Dependovirus | 1 | 2017 | 706 | 0.100 |
Why?
|
| Metabolomics | 1 | 2020 | 1484 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2012 | 41 | 0.100 |
Why?
|
| Insulator Elements | 1 | 2011 | 27 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2011 | 25 | 0.100 |
Why?
|
| Carbazoles | 1 | 2013 | 226 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 425 | 0.100 |
Why?
|
| Lipids | 1 | 2023 | 3305 | 0.100 |
Why?
|
| Human Growth Hormone | 3 | 2007 | 683 | 0.100 |
Why?
|
| In Situ Hybridization | 4 | 2002 | 1950 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 3870 | 0.100 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2013 | 282 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 3 | 2021 | 2657 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2012 | 246 | 0.100 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 2012 | 68 | 0.100 |
Why?
|
| Semaphorin-3A | 1 | 2011 | 39 | 0.100 |
Why?
|
| Culture Media | 1 | 2013 | 908 | 0.100 |
Why?
|
| Nerve Degeneration | 2 | 2014 | 748 | 0.100 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 813 | 0.100 |
Why?
|
| Cell Survival | 1 | 2001 | 5882 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 666 | 0.090 |
Why?
|
| Pericytes | 1 | 2013 | 292 | 0.090 |
Why?
|
| Telangiectasis | 1 | 2010 | 76 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 742 | 0.090 |
Why?
|
| Breast Feeding | 1 | 2019 | 1338 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 2 | 2011 | 611 | 0.090 |
Why?
|
| ROC Curve | 4 | 2020 | 3527 | 0.090 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 745 | 0.090 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1995 | 546 | 0.090 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 190 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 270 | 0.090 |
Why?
|
| Calpain | 1 | 2010 | 150 | 0.090 |
Why?
|
| Stem Cell Research | 1 | 2010 | 56 | 0.090 |
Why?
|
| Serpins | 2 | 2016 | 247 | 0.090 |
Why?
|
| Infusions, Intravenous | 4 | 2018 | 2274 | 0.090 |
Why?
|
| Macula Lutea | 1 | 2010 | 151 | 0.090 |
Why?
|
| Cryosurgery | 1 | 2014 | 453 | 0.090 |
Why?
|
| Reference Standards | 1 | 2013 | 1025 | 0.090 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2014 | 582 | 0.090 |
Why?
|
| RNA | 3 | 2012 | 2749 | 0.090 |
Why?
|
| Longitudinal Studies | 5 | 2018 | 13989 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 1456 | 0.090 |
Why?
|
| Fluoresceins | 3 | 1994 | 235 | 0.090 |
Why?
|
| Pulmonary Alveoli | 1 | 2012 | 675 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 3617 | 0.090 |
Why?
|
| Ghrelin | 1 | 2011 | 266 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 1990 | 0.090 |
Why?
|
| Retinal Vein Occlusion | 1 | 2010 | 137 | 0.090 |
Why?
|
| Zinc Fingers | 1 | 2011 | 585 | 0.080 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2008 | 35 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2503 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 1992 | 597 | 0.080 |
Why?
|
| Anemia | 1 | 2018 | 1506 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1403 | 0.080 |
Why?
|
| Long-Term Potentiation | 1 | 2010 | 293 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1889 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 3772 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 8301 | 0.080 |
Why?
|
| Leptin | 2 | 2015 | 1599 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 1179 | 0.080 |
Why?
|
| Anemia, Neonatal | 1 | 2008 | 18 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 430 | 0.080 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2010 | 245 | 0.080 |
Why?
|
| Sentinel Surveillance | 1 | 2010 | 281 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 1970 | 0.080 |
Why?
|
| Dissection | 1 | 2009 | 295 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2012 | 721 | 0.080 |
Why?
|
| Prognosis | 5 | 2023 | 29063 | 0.080 |
Why?
|
| Algorithms | 8 | 2013 | 13881 | 0.080 |
Why?
|
| Dextrans | 3 | 1994 | 595 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1114 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 11366 | 0.070 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 271 | 0.070 |
Why?
|
| Phospholipids | 2 | 2023 | 784 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2007 | 123 | 0.070 |
Why?
|
| Parturition | 1 | 2010 | 441 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 456 | 0.070 |
Why?
|
| Rats | 6 | 2017 | 24260 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1375 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15519 | 0.070 |
Why?
|
| Macular Edema | 1 | 2010 | 359 | 0.070 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2016 | 341 | 0.070 |
Why?
|
| DNA Repair | 1 | 2016 | 2046 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 1285 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2018 | 53288 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17446 | 0.070 |
Why?
|
| Cell Line | 4 | 2013 | 15997 | 0.070 |
Why?
|
| Injections | 1 | 2008 | 840 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2866 | 0.070 |
Why?
|
| Free Radicals | 1 | 2005 | 237 | 0.070 |
Why?
|
| Phenotype | 4 | 2016 | 16365 | 0.070 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 57776 | 0.060 |
Why?
|
| Arachidonic Acids | 1 | 2005 | 299 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2010 | 2327 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7322 | 0.060 |
Why?
|
| Fetal Growth Retardation | 2 | 2011 | 570 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.060 |
Why?
|
| Astrocytes | 2 | 2021 | 1270 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5442 | 0.060 |
Why?
|
| Chromatin | 2 | 2017 | 2934 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 250 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1708 | 0.060 |
Why?
|
| False Positive Reactions | 3 | 2012 | 981 | 0.060 |
Why?
|
| Glucose | 1 | 2016 | 4397 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2008 | 375 | 0.060 |
Why?
|
| Lymphatic Abnormalities | 1 | 2005 | 133 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 472 | 0.060 |
Why?
|
| Aging | 2 | 2013 | 8664 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2109 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2011 | 3023 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2440 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 689 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2010 | 2263 | 0.050 |
Why?
|
| Sepsis | 1 | 2016 | 2593 | 0.050 |
Why?
|
| Optic Nerve | 3 | 2001 | 554 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 916 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2010 | 1149 | 0.050 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2023 | 122 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 638 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 19905 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2203 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1161 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 2050 | 0.050 |
Why?
|
| Brain | 3 | 2018 | 26385 | 0.050 |
Why?
|
| Visual Perception | 1 | 2010 | 1420 | 0.050 |
Why?
|
| Child Development | 3 | 2018 | 2223 | 0.050 |
Why?
|
| Genotype | 1 | 2016 | 12951 | 0.050 |
Why?
|
| Orbit | 1 | 2005 | 426 | 0.050 |
Why?
|
| Ceramides | 1 | 2022 | 199 | 0.050 |
Why?
|
| Extracellular Matrix | 3 | 2017 | 1741 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2916 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2006 | 645 | 0.050 |
Why?
|
| Disease Progression | 3 | 2013 | 13284 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2021 | 12026 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2023 | 40561 | 0.050 |
Why?
|
| Learning | 1 | 2010 | 1713 | 0.050 |
Why?
|
| Axonal Transport | 1 | 2001 | 177 | 0.050 |
Why?
|
| Head | 1 | 2006 | 880 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3768 | 0.050 |
Why?
|
| Memory | 1 | 2010 | 2174 | 0.050 |
Why?
|
| Receptor, trkB | 1 | 2001 | 125 | 0.050 |
Why?
|
| Oximetry | 2 | 2016 | 471 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2008 | 2309 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 687 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2569 | 0.050 |
Why?
|
| United States | 3 | 2017 | 69872 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 426 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2003 | 644 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1581 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2021 | 513 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2889 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2002 | 520 | 0.040 |
Why?
|
| Child | 8 | 2022 | 77709 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 893 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1676 | 0.040 |
Why?
|
| Base Sequence | 3 | 2001 | 12797 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2016 | 625 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2002 | 11124 | 0.040 |
Why?
|
| Cesarean Section | 2 | 2022 | 1365 | 0.040 |
Why?
|
| Time Factors | 4 | 2016 | 40075 | 0.040 |
Why?
|
| Serine | 1 | 2022 | 826 | 0.040 |
Why?
|
| Aged | 8 | 2020 | 163280 | 0.040 |
Why?
|
| Face | 1 | 2005 | 994 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2023 | 638 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 421 | 0.040 |
Why?
|
| Cell Movement | 3 | 2017 | 5217 | 0.040 |
Why?
|
| Hypothalamus | 1 | 1984 | 1063 | 0.040 |
Why?
|
| Vision Disorders | 2 | 2022 | 1058 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2022 | 545 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 385 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2019 | 192 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9648 | 0.040 |
Why?
|
| Chromatography, Gas | 1 | 2018 | 156 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2004 | 1172 | 0.040 |
Why?
|
| Developing Countries | 1 | 2010 | 2815 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2018 | 8324 | 0.040 |
Why?
|
| Hippocampus | 1 | 2010 | 3675 | 0.040 |
Why?
|
| Triplets | 1 | 1997 | 43 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 2009 | 919 | 0.040 |
Why?
|
| Soybean Oil | 1 | 2018 | 133 | 0.040 |
Why?
|
| Plant Oils | 1 | 2018 | 202 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 5892 | 0.040 |
Why?
|
| Hormone Antagonists | 1 | 1997 | 108 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2021 | 63114 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 14722 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2021 | 604 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2005 | 2132 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 1572 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 610 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 4186 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1769 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2016 | 41006 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1097 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2008 | 3743 | 0.030 |
Why?
|
| Mutation | 3 | 2019 | 29786 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1730 | 0.030 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 1995 | 24 | 0.030 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 347 | 0.030 |
Why?
|
| Semaphorins | 1 | 2016 | 101 | 0.030 |
Why?
|
| Recurrence | 2 | 2018 | 8340 | 0.030 |
Why?
|
| Cerebral Aqueduct | 1 | 1995 | 39 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 862 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 635 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2016 | 180 | 0.030 |
Why?
|
| Collagen | 2 | 2002 | 2689 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2016 | 21746 | 0.030 |
Why?
|
| Logistic Models | 2 | 2021 | 13408 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2012 | 780 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1997 | 400 | 0.030 |
Why?
|
| Rabbits | 1 | 2021 | 4894 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2001 | 2375 | 0.030 |
Why?
|
| Stem Cells | 1 | 2008 | 3567 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2005 | 3002 | 0.030 |
Why?
|
| Amino Acids | 1 | 2020 | 1736 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2001 | 1538 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5535 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2011 | 1799 | 0.030 |
Why?
|
| Term Birth | 1 | 2014 | 135 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 1085 | 0.030 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2016 | 629 | 0.030 |
Why?
|
| Lectins | 2 | 1994 | 513 | 0.030 |
Why?
|
| Age Factors | 1 | 2010 | 18370 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 565 | 0.030 |
Why?
|
| Muramidase | 1 | 1973 | 174 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 2016 | 314 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 551 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.030 |
Why?
|
| Computational Biology | 2 | 2021 | 3521 | 0.030 |
Why?
|
| Endothelium | 1 | 1995 | 778 | 0.030 |
Why?
|
| Dark Adaptation | 1 | 1994 | 219 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1995 | 659 | 0.030 |
Why?
|
| Cognition | 1 | 2010 | 6770 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 2382 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1997 | 1227 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2016 | 2751 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 913 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 791 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 1984 | 2624 | 0.030 |
Why?
|
| Cryotherapy | 1 | 2013 | 155 | 0.030 |
Why?
|
| Mitomycins | 1 | 1992 | 47 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9386 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1850 | 0.030 |
Why?
|
| Gene Expression | 2 | 2014 | 7799 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1301 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2003 | 3279 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 843 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 9727 | 0.020 |
Why?
|
| Homeostasis | 1 | 2022 | 3340 | 0.020 |
Why?
|
| Adrenal Cortex | 1 | 1992 | 140 | 0.020 |
Why?
|
| Cataract | 2 | 1995 | 834 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 351 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 2255 | 0.020 |
Why?
|
| Retinal Pigments | 1 | 2010 | 83 | 0.020 |
Why?
|
| Survival Rate | 2 | 2022 | 12788 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2219 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8642 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 15076 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 2455 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2020 | 5102 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6538 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 203 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 582 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5097 | 0.020 |
Why?
|
| Time | 1 | 2011 | 542 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 235 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2240 | 0.020 |
Why?
|
| Perfusion | 1 | 1994 | 1360 | 0.020 |
Why?
|
| Transcription Factors, TFII | 1 | 2009 | 60 | 0.020 |
Why?
|
| Retinal Perforations | 1 | 2010 | 131 | 0.020 |
Why?
|
| Canada | 1 | 2014 | 2065 | 0.020 |
Why?
|
| Random Allocation | 1 | 1994 | 2429 | 0.020 |
Why?
|
| Visual Pathways | 2 | 1984 | 565 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 1026 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1318 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9849 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16689 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2010 | 233 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1988 | 104 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 1 | 2009 | 161 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 405 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1184 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6314 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 661 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2010 | 698 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2002 | 6364 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 964 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39050 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5952 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1547 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2017 | 3420 | 0.020 |
Why?
|
| Reference Values | 2 | 2006 | 4982 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1525 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2010 | 752 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 1270 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 2118 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 1236 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3462 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2432 | 0.020 |
Why?
|
| Adult | 7 | 2020 | 214055 | 0.020 |
Why?
|
| Picibanil | 1 | 2005 | 10 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2010 | 1185 | 0.020 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2004 | 13 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 1059 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2010 | 2421 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 581 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2004 | 61 | 0.020 |
Why?
|
| Receptor, PAR-2 | 1 | 2004 | 32 | 0.020 |
Why?
|
| Insulin | 1 | 1999 | 6580 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2005 | 220 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12245 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 3778 | 0.020 |
Why?
|
| Middle Aged | 7 | 2020 | 213383 | 0.020 |
Why?
|
| Acute Disease | 1 | 1995 | 7149 | 0.020 |
Why?
|
| Eye Infections | 1 | 2005 | 64 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 1984 | 87 | 0.010 |
Why?
|
| Cell Division | 1 | 1992 | 4568 | 0.010 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1655 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3144 | 0.010 |
Why?
|
| Exophthalmos | 1 | 2005 | 97 | 0.010 |
Why?
|
| Macaca | 1 | 2005 | 440 | 0.010 |
Why?
|
| Sclerotherapy | 1 | 2005 | 175 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 1678 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2004 | 251 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1995 | 4560 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 2005 | 143 | 0.010 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1984 | 147 | 0.010 |
Why?
|
| Cerebral Veins | 1 | 2005 | 156 | 0.010 |
Why?
|
| Glucosamine | 2 | 1973 | 132 | 0.010 |
Why?
|
| Cyclohexanes | 1 | 2003 | 152 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2005 | 982 | 0.010 |
Why?
|
| Abnormalities, Multiple | 2 | 2005 | 1416 | 0.010 |
Why?
|
| Tritium | 2 | 1973 | 745 | 0.010 |
Why?
|
| Neurofibromin 1 | 1 | 2004 | 196 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 18111 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
| Pedigree | 1 | 2010 | 4644 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1801 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2003 | 424 | 0.010 |
Why?
|
| Sesquiterpenes | 1 | 2003 | 177 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 23338 | 0.010 |
Why?
|
| Actins | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2004 | 350 | 0.010 |
Why?
|
| Phenylenediamines | 1 | 1983 | 90 | 0.010 |
Why?
|
| Melanoma | 1 | 2001 | 5510 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5853 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 2002 | 76 | 0.010 |
Why?
|
| Endostatins | 1 | 2002 | 174 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 1200 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 708 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 2472 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 572 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 643 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10388 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 2872 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2004 | 1901 | 0.010 |
Why?
|
| Edema | 1 | 2005 | 789 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 934 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3086 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1009 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 12959 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6365 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 1686 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 838 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 1723 | 0.010 |
Why?
|
| Axons | 2 | 1984 | 1684 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1988 | 1519 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2307 | 0.010 |
Why?
|
| Adolescent | 3 | 2018 | 85781 | 0.010 |
Why?
|
| Maleimides | 1 | 1997 | 112 | 0.010 |
Why?
|
| Patient Selection | 1 | 2009 | 4215 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.010 |
Why?
|
| Hydrolysis | 2 | 1973 | 682 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 6114 | 0.010 |
Why?
|
| Tooth, Impacted | 1 | 1995 | 42 | 0.010 |
Why?
|
| Acetamides | 2 | 1973 | 249 | 0.010 |
Why?
|
| Cadherins | 1 | 1999 | 907 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1992 | 11483 | 0.010 |
Why?
|
| Chitin | 1 | 1973 | 41 | 0.010 |
Why?
|
| Chemistry | 1 | 1973 | 352 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1973 | 518 | 0.010 |
Why?
|
| Methods | 1 | 1973 | 1129 | 0.010 |
Why?
|
| Glycosides | 1 | 1973 | 107 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 5255 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1995 | 544 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 3461 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1997 | 1726 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 5720 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 20947 | 0.010 |
Why?
|
| Catalysis | 1 | 1973 | 761 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1107 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 4669 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56430 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1973 | 414 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.010 |
Why?
|
| Syndrome | 1 | 1995 | 3251 | 0.010 |
Why?
|
| Kinetics | 2 | 1973 | 6473 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 4364 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1988 | 356 | 0.000 |
Why?
|
| Laminin | 1 | 1988 | 419 | 0.000 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1988 | 365 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3798 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 8949 | 0.000 |
Why?
|
| Drosophila melanogaster | 1 | 1973 | 1708 | 0.000 |
Why?
|
| Neoplasms | 1 | 2011 | 21683 | 0.000 |
Why?
|
| Epitopes | 1 | 1988 | 2571 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1988 | 2699 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 964 | 0.000 |
Why?
|
| Models, Structural | 1 | 1973 | 361 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1973 | 563 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1973 | 577 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 3523 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1973 | 406 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1973 | 2557 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1973 | 3129 | 0.000 |
Why?
|
| Water | 1 | 1973 | 1395 | 0.000 |
Why?
|